LFG
ANVS icon

Larson Financial Group’s Annovis Bio ANVS Stock Holding History

Larson Financial Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558 Hold
300
– – ﹤0.01% 3465
2026
Q1 		$669 Hold
300
– – ﹤0.01% 3258
2025
Q4 		$1.04K Hold
300
– – ﹤0.01% 2942
2025
Q3 		$621 Hold
300
– – ﹤0.01% 3052
2025
Q2 		$651 Buy
300
+150
+100% +$296 ﹤0.01% 2780
2025
Q1 		$225 Buy
+150
New +$459 ﹤0.01% 2767

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Larson Financial Group's ANVS Position: Q2 2026 in Review

Larson Financial Group held its Annovis Bio (ANVS) position steady in Q2 2026 at 300 shares worth $558. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

Larson Financial Group first reported a position in ANVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.04K in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Larson Financial Group held 300 shares of Annovis Bio worth $558 as of Q2 2026.
  • Larson Financial Group left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3465 holding.
  • Larson Financial Group first reported a position in Annovis Bio in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Annovis Bio position peaked at $1.04K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.